Difference between revisions of "LINC-ROR"
(→References) |
|||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | + | ''LINC-ROR'', a long non-coding RNA gene that regulates the reprogramming of pluripotent stem cells. | |
==Annotated Information== | ==Annotated Information== | ||
===Name=== | ===Name=== | ||
| − | LINC-ROR:long intergenic non-protein coding RNA, regulator of reprogramming | + | Approved symbol: LINC-ROR |
| + | |||
| + | Approved name: long intergenic non-protein coding RNA, regulator of reprogramming | ||
| + | |||
| + | HGNC ID: HGNC:43773 | ||
| + | |||
| + | Previous names: 7SK, 7SK small nuclear | ||
| − | lincRNA-ST8SIA3 | + | Alias symbols: lincRNA-RoR; lincRNA-ST8SIA3; ROR |
| − | + | RefSeq ID: NR_048536 | |
===Characteristics=== | ===Characteristics=== | ||
| − | The LINC-ROR gene is 2.6 kb in length, located in chromosome 18 (18q21.31), consisting of four exons <ref name="ref2" />. | + | The ''LINC-ROR'' gene is 2.6 kb in length, located in chromosome 18 (18q21.31), consisting of four exons <ref name="ref2" />. |
===Function=== | ===Function=== | ||
| − | LINC-ROR is first found to modulate reprogramming of human induced pluripotent stem cells <ref name="ref1" />. | + | ''LINC-ROR'' is first found to modulate reprogramming of human induced pluripotent stem cells. ''LINC-ROR'' is p53 repressor in response to DNA damage <ref name="ref1" />. |
| − | LINC-ROR | + | ''LINC-ROR'' can suppress p53 translation through direct interaction with the heterogeneous nuclear ribonucleoprotein I (hnRNP I), and inhibit p53-mediated cell cycle arrest and apoptosis <ref name="ref2" />. |
| − | LINC-ROR also functions as an endogenous miRNA sponge and antagonizes miR-145 to critically regulate the levels of pluripotency transcription factors Oct4, Sox2, and Nanog, in order to ensure embryonic stem cell self-renewal <ref name="ref3" /><ref name="ref4" />. | + | ''LINC-ROR'' also functions as an endogenous miRNA sponge and antagonizes miR-145 to critically regulate the levels of pluripotency transcription factors Oct4, Sox2, and Nanog, in order to ensure embryonic stem cell self-renewal <ref name="ref3" /><ref name="ref4" />. |
| − | [[File:LincRNA-RoR-1.JPG|right|thumb|600px|'''A competition for miR-145 between linc-RoR and mRNAs encoding the core TFs'''<ref name="ref4"/>.]] | + | [[File:LincRNA-RoR-1.JPG|right|thumb|600px|'''A competition for miR-145 between ''linc-RoR'' and mRNAs encoding the core TFs'''<ref name="ref4"/>.]] |
| − | LINC-ROR is involved in modulation of hypoxia-signaling pathways through modulation of HIF-1a and its downstream targets <ref name="ref5" />. | + | ''LINC-ROR'' is involved in modulation of hypoxia-signaling pathways through modulation of HIF-1a and its downstream targets <ref name="ref5" />. |
===Regulation=== | ===Regulation=== | ||
| − | LINC-ROR and p53 form a RoR-p53 autoregulatory feedback loop where p53 transcriptionally induces RoR expression <ref name="ref2" />. | + | ''LINC-ROR'' and p53 form a RoR-p53 autoregulatory feedback loop where p53 transcriptionally induces RoR expression <ref name="ref2" />. |
| − | LINC-ROR transcription is mainly controlled by the core TFs Oct4, Sox2, and Nanog <ref name="ref1" /><ref name="ref3" /><ref name="ref4" />. | + | ''LINC-ROR'' transcription is mainly controlled by the core TFs Oct4, Sox2, and Nanog <ref name="ref1" /><ref name="ref3" /><ref name="ref4" />. |
===Diseases=== | ===Diseases=== | ||
| Line 31: | Line 37: | ||
===Expression=== | ===Expression=== | ||
| − | LINC-ROR is highly expressed in embryonic stem cells and iPSCs <ref name="ref2" />. | + | ''LINC-ROR'' is highly expressed in embryonic stem cells and iPSCs <ref name="ref2" />. |
| − | In self-renewing human embryonic stem cells (hESCs), LINC-ROR is expressed at a high level <ref name="ref3" /><ref name="ref4" />. | + | In self-renewing human embryonic stem cells (hESCs), ''LINC-ROR'' is expressed at a high level <ref name="ref3" /><ref name="ref4" />. |
| − | LINC-ROR expression is increased in hypoxic regions within tumor cell xenografts in vivo and is highly expressed in extracellular RNA released by hepatocellular cancer (HCC) cells during hypoxia <ref name="ref5" />. | + | ''LINC-ROR'' expression is increased in hypoxic regions within tumor cell xenografts in vivo and is highly expressed in extracellular RNA released by hepatocellular cancer (HCC) cells during hypoxia <ref name="ref5" />. |
===Sequence=== | ===Sequence=== | ||
Latest revision as of 06:15, 10 August 2019
LINC-ROR, a long non-coding RNA gene that regulates the reprogramming of pluripotent stem cells.
Contents
Annotated Information
Name
Approved symbol: LINC-ROR
Approved name: long intergenic non-protein coding RNA, regulator of reprogramming
HGNC ID: HGNC:43773
Previous names: 7SK, 7SK small nuclear
Alias symbols: lincRNA-RoR; lincRNA-ST8SIA3; ROR
RefSeq ID: NR_048536
Characteristics
The LINC-ROR gene is 2.6 kb in length, located in chromosome 18 (18q21.31), consisting of four exons [1].
Function
LINC-ROR is first found to modulate reprogramming of human induced pluripotent stem cells. LINC-ROR is p53 repressor in response to DNA damage [2].
LINC-ROR can suppress p53 translation through direct interaction with the heterogeneous nuclear ribonucleoprotein I (hnRNP I), and inhibit p53-mediated cell cycle arrest and apoptosis [1].
LINC-ROR also functions as an endogenous miRNA sponge and antagonizes miR-145 to critically regulate the levels of pluripotency transcription factors Oct4, Sox2, and Nanog, in order to ensure embryonic stem cell self-renewal [3][4].
LINC-ROR is involved in modulation of hypoxia-signaling pathways through modulation of HIF-1a and its downstream targets [5].
Regulation
LINC-ROR and p53 form a RoR-p53 autoregulatory feedback loop where p53 transcriptionally induces RoR expression [1].
LINC-ROR transcription is mainly controlled by the core TFs Oct4, Sox2, and Nanog [2][3][4].
Diseases
malignant liver cancer [5]
Expression
LINC-ROR is highly expressed in embryonic stem cells and iPSCs [1].
In self-renewing human embryonic stem cells (hESCs), LINC-ROR is expressed at a high level [3][4].
LINC-ROR expression is increased in hypoxic regions within tumor cell xenografts in vivo and is highly expressed in extracellular RNA released by hepatocellular cancer (HCC) cells during hypoxia [5].
Sequence
>NR_048536.1 Homo sapiens long intergenic non-protein coding RNA, regulator of reprogramming (LINC-ROR), long non-coding RNA
000081 TGACTCGGAT AGGGGGACCT CCCTTGGGAG ATCAGTACCC TGTCCTCCTG CTCTTTGCTC CGTGAGAAAG ATCCACCTAC 000160
000161 AACCTCAGGT CCTTAGACCA ACCAGCCCAA GAAACATCTC ACCAATTTCA AATCCAGACC CCACTGGAAA TCGGACTGTC 000240
000241 CAACTCACCT GACAGCCACT CCCACAGCCG CTGGAACTCT GGCCCAAGGC TCTCTGACTC CTTCCCAGAT CTTCTTGGCT 000320
000321 TAGCGGCTGA AGACTGACGC TGCCCGATCG CCTCGGAAGC CCCCTAGACC ATCACGGACG CCGAGCTTCG GGTAACTCTC 000400
000401 ACAGTGGAAG AAACACAACT ACAGATTTCT ACCTGGTGCA TGGCCATCGC TCATGAAGAC TACAACTTCC AGCTTCCTTT 000480
000481 GAAGAAAAAG AGGACTTGAT GGCATTGTCG CTAAGTAAGA AATAATGTGT GTGACTTCAG GGTTGCCCCC TTAAAGGGAG 000560
000561 GGGACATTTT CCATCCTGCT GTTCAGAGTA TGGATGTGAT GAGAGACATC TTGGATGATG CAGAGGAGGT GAACACCCCA 000640
000641 GGACAATGAA ACCACAGGAG AGAAAGAGCC TGCGCTGGCC CATCTAGCAC AGCCACTGGA CACAGGGACC ACCTGCCTCT 000720
000721 GCACTCTTAT GGAAGGAGGA AATCTAACTT TCCCAGTTTA AGGCACTGTT ACTTTGGGCT CCTGTTACAT AACTGTGGCA 000800
000801 GAATGAAGGT TCAACATGGA AACTGGCAAT GTTGAAGAAA CATAAAGTTC ATTGCTTGAA TATCTGAAGT TGTGGACTCA 000880
000881 ATCTCATACC TGCTCCACTT ATGAGTTATA GTTCTTCCAG GTCTCAGGAA TGGGATCAGC AGGTCTCAGG GTTGTACTCT 000960
000961 CCTGGATCTC TCACCAGCCA CCTCAAACCA GCTGCCATAG CCTGTCCACT TCCACTCCAA TCTTCTCTTC CTTCATCACC 001040
001041 TCCCTTGCAC ACCCTGATAA CCTCGAAAGA GAACTCTTCC CAAGGCTCTG TTCCAAACAC ATCGCCACTC TGCTTAGAAC 001120
001121 CTTCAATGAC TCCTCATGGC CTAGGAGGTT TCTCTCCCAT CTGGATCCAG CTGACGTTCC CAGCACCTTC TCCTGACTCC 001200
001201 TGTCTTTTCT TGAACCAGTT CTGCCCAACA AGGAGGAAAG GGCTGACAGA GTGAAAGTCC CAGGGCATGT GGGAATGTGA 001280
001281 CTCTTTTCAC TTTAAATTCT ATGACTGGAA AGTTTTGGGC AGAGTTGGAC ATGTGCACTT AGCTTCCAGA AGACAGAATC 001360
001361 CTTTTAAAAG AGTCAGAGAA AACACTGGCT TCCTGCCATG ACATGAGATA CAGACAGGAG AGTTGGGAAG CTTTTTAAAG 001440
001441 ATGGCACTAT GACTACAATC ACAGAAACTC TCCATGAGGA AGTAAAAGAA AGCACCTGCA ACACTCCAGC TATGCAGACC 001520
001521 ACTCTGTAAT GGGCTCAGAT CTGGACAGGT GTGTGGAAAG GTGGGTCAAC AGGTCAGGCG TCACAGACTT GGAACATTCA 001600
001601 TGGTGGAAAA GAAAAAGCCC CAAAGAAGAG ACTTCAGGAT AAATGAGAAA ATACTCAAGA CAGCAAAAGT CTCTTTTAGA 001680
001681 AATGTTGGAG AAAGAACACT TAATGTCAGG AGTTACTGT